In this video interview, Kimberly Tableman, founder & CEO, ESPERO, discusses historical challenges with long protocol ...

Pilot trial shows that a user-friendly electronic patient-reported outcome (ePRO) monitoring system significantly improves ...

In this video interview, Sujay Jadhav, CEO of Verana Health, highlights the role of real-world evidence alongside unstructured and structured data in better understanding the patient journey. In a ...

Phase III IRAKLIA trial shows that subcutaneous Sarclisa delivered via an on-body delivery system is as effective and safe as intravenous administration in treating relapsed or refractory multiple ...

In this video interview, Sujay Jadhav, CEO of Verana Health, discusses how using genomic data and real-world evidence can provide added context to traditional factors such as Gleason scores and PSA ...

A Phase Ib/II dose escalation and expansion trial shows promising antitumor activity and durable responses with Talvey (talquetamab) plus Tecvayli (teclistamab) in the treatment of relapsed or ...

Initial data from Phase I clinical trial showed encouraging single agent activity in patients with different types of PD-1 resistant tumors. The FDA has granted Fast Track designation to Marengo ...

In this video interview, Sujay Jadhav, CEO of Verana Health, talks AI and its role in optimizing trial design. In a recent video interview with Applied Clinical Trials, Sujay Jadhav, CEO of Verana ...

In this video interview, Sujay Jadhav, CEO of Verana Health, highlights how the industry can use RWD to compare outcomes from treatment and non-treatment arms. In a recent video interview with Applied ...

Results from the Phase III MARIPOSA trial demonstrated the combination of Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib) significantly improves overall survival compared to the current ...

Over the past two years, generative artificial intelligence (AI) has emerged as a top strategic priority in the life sciences industry, driving innovation across drug development and regulatory ...

In this video interview, Sujay Jadhav, CEO of Verana Health, discusses how the use of unstructured data can help improve clinical research in 2025. In a recent video interview with Applied Clinical ...